South & Central America Vaccines Market Size and Forecast (2021 - 2031)
The South & Central America Vaccines Market is projected to grow from US$ 4,593.3 Million in 2024 to US$ 6,576.1 Million by 2031, reflecting a compound annual growth rate (CAGR) of 5.3% from 2025 to 2031.
Executive Summary and Market Analysis
The vaccine market in South & Central America is primarily segmented into Brazil, Argentina, and other regions. Brazil stands out as the leading contributor to the market, with Argentina also showing significant growth. The increasing demand for vaccines is driven by heightened awareness of immunization and the prevention of infectious diseases. Local manufacturers are investing in research to improve vaccine efficacy and coverage through advanced technologies. Additionally, government initiatives, including national health programs and public-private partnerships, are enhancing vaccine production and accessibility, thereby strengthening public health systems and aiming for universal immunization coverage. These combined efforts are fostering a favorable environment for sustained growth in the vaccine market across the region.
Strategic Insights
Market Segmentation
The World Health Organization (WHO) has identified over 30 priority pathogens that pose risks for global public health emergencies, including influenza A, dengue, and monkeypox viruses. The frequency of infectious disease outbreaks has risen globally, with notable increases in cases of diseases like dengue. As of April 2024, the Americas reported over 7 million dengue cases, surpassing previous records. The WHO also highlighted the ongoing challenges posed by hepatitis B and C, with millions affected and a significant portion undiagnosed.
Outbreaks of contagious diseases lead to increased demand for vaccines, as seen during the COVID-19 pandemic, which spurred unprecedented global vaccination efforts. The WHO estimates that immunization has saved approximately 154 million lives over the past 50 years, underscoring the critical role of vaccines in public health.
Country Insights
The South & Central America Vaccines Market is further divided by country, with Brazil holding the largest share in 2024. The Brazilian government is actively enhancing vaccination coverage and has recently launched its first domestically developed dengue vaccine, supported by substantial investments. Brazil aims for complete national production of the dengue vaccine by 2026 and has initiated campaigns to vaccinate millions of children against dengue.
Company Profiles
Key players in the South & Central America Vaccines Market include Abbott Laboratories, GSK Plc, Pfizer Inc., Merck & Co. Inc., Novartis AG, Sanofi SA, CSL Ltd, Serum Institute of India Pvt Ltd, BioNTech SE, and Sinovac Biotech Ltd. These companies are pursuing strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative solutions.
Executive Summary and Market Analysis
The vaccine market in South & Central America is primarily segmented into Brazil, Argentina, and other regions. Brazil stands out as the leading contributor to the market, with Argentina also showing significant growth. The increasing demand for vaccines is driven by heightened awareness of immunization and the prevention of infectious diseases. Local manufacturers are investing in research to improve vaccine efficacy and coverage through advanced technologies. Additionally, government initiatives, including national health programs and public-private partnerships, are enhancing vaccine production and accessibility, thereby strengthening public health systems and aiming for universal immunization coverage. These combined efforts are fostering a favorable environment for sustained growth in the vaccine market across the region.
Strategic Insights
Market Segmentation
- By Type: The market is categorized into Conjugated Vaccines, Inactivated Vaccines, Live Vaccines, Recombinant Vaccines, and Toxoid Vaccines, with Conjugated Vaccines holding the largest market share in 2024.
- By Indication: Segmented into HPV, PCV, DTP, Hepatitis, Influenza, Dengue, and others, where the HPV segment leads in market share for 2024.
- By Route of Administration: The market is divided into Injection, Oral, and Other, with the Injection segment being the most significant in 2024.
- By Age Group: The market is split into Pediatric and Adult segments, with Pediatrics dominating in 2024.
The World Health Organization (WHO) has identified over 30 priority pathogens that pose risks for global public health emergencies, including influenza A, dengue, and monkeypox viruses. The frequency of infectious disease outbreaks has risen globally, with notable increases in cases of diseases like dengue. As of April 2024, the Americas reported over 7 million dengue cases, surpassing previous records. The WHO also highlighted the ongoing challenges posed by hepatitis B and C, with millions affected and a significant portion undiagnosed.
Outbreaks of contagious diseases lead to increased demand for vaccines, as seen during the COVID-19 pandemic, which spurred unprecedented global vaccination efforts. The WHO estimates that immunization has saved approximately 154 million lives over the past 50 years, underscoring the critical role of vaccines in public health.
Country Insights
The South & Central America Vaccines Market is further divided by country, with Brazil holding the largest share in 2024. The Brazilian government is actively enhancing vaccination coverage and has recently launched its first domestically developed dengue vaccine, supported by substantial investments. Brazil aims for complete national production of the dengue vaccine by 2026 and has initiated campaigns to vaccinate millions of children against dengue.
Company Profiles
Key players in the South & Central America Vaccines Market include Abbott Laboratories, GSK Plc, Pfizer Inc., Merck & Co. Inc., Novartis AG, Sanofi SA, CSL Ltd, Serum Institute of India Pvt Ltd, BioNTech SE, and Sinovac Biotech Ltd. These companies are pursuing strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative solutions.
1. INTRODUCTION
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
2.2 Market Attractiveness
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. SOUTH & CENTRAL AMERICA VACCINES MARKET LANDSCAPE
4.1 Market Overview
4.2 PEST Analysis
5. VACCINES MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. VACCINES MARKET - SOUTH & CENTRAL AMERICA MARKET ANALYSIS
6.1 South & Central America Vaccines Market Revenue (US$ Million), 2024 - 2031
6.2 South & Central America Vaccines Market Forecast and Analysis
7. SOUTH & CENTRAL AMERICA VACCINES MARKET REVENUE ANALYSIS - BY TYPE
7.1 Conjugated
7.1.1 Overview
7.1.2 Conjugated: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Inactivated
7.2.1 Overview
7.2.2 Inactivated: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.3 Live
7.3.1 Overview
7.3.2 Live: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.4 Recombinant
7.4.1 Overview
7.4.2 Recombinant: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.5 Toxoid
7.5.1 Overview
7.5.2 Toxoid: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. SOUTH & CENTRAL AMERICA VACCINES MARKET REVENUE ANALYSIS - BY INDICATION
8.1 HPV
8.1.1 Overview
8.1.2 HPV: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 PCV
8.2.1 Overview
8.2.2 PCV: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3 DTP
8.3.1 Overview
8.3.2 DTP: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.4 Hepatitis
8.4.1 Overview
8.4.2 Hepatitis: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.5 Influenza
8.5.1 Overview
8.5.2 Influenza: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.6 Dengue
8.6.1 Overview
8.6.2 Dengue: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.7 Other
8.7.1 Overview
8.7.2 Other: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. SOUTH & CENTRAL AMERICA VACCINES MARKET REVENUE ANALYSIS - BY ROUTE OF ADMINISTRATION
9.1 Injection
9.1.1 Overview
9.1.2 Injection: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Oral
9.2.1 Overview
9.2.2 Oral: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.3 Other
9.3.1 Overview
9.3.2 Other: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. SOUTH & CENTRAL AMERICA VACCINES MARKET REVENUE ANALYSIS - BY AGE GROUP
10.1 Pediatric
10.1.1 Overview
10.1.2 Pediatric: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2 Adult
10.2.1 Overview
10.2.2 Adult: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11. SOUTH & CENTRAL AMERICA VACCINES MARKET - COUNTRY ANALYSIS
11.1 South & Central America
11.1.1 South & Central America Vaccines Market Revenue and Forecast and Analysis - by Country
11.1.1.1 South & Central America Vaccines Market Revenue and Forecast and Analysis - by Country
11.1.2.2 Brazil: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.1.2.2.1 Brazil: South & Central America Vaccines Market Share - by Type
11.1.2.2.2 Brazil: South & Central America Vaccines Market Share - by Indication
11.1.2.2.3 Brazil: South & Central America Vaccines Market Share - by Route Of Administration
11.1.2.2.4 Brazil: South & Central America Vaccines Market Share - by Age Group
11.2.3.3 Argentina: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.2.3.3.1 Argentina: South & Central America Vaccines Market Share - by Type
11.2.3.3.2 Argentina: South & Central America Vaccines Market Share - by Indication
11.2.3.3.3 Argentina: South & Central America Vaccines Market Share - by Route Of Administration
11.2.3.3.4 Argentina: South & Central America Vaccines Market Share - by Age Group
11.3.4.4 Rest of South & Central America: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.3.4.4.1 Rest of South & Central America: South & Central America Vaccines Market Share - by Type
11.3.4.4.2 Rest of South & Central America: South & Central America Vaccines Market Share - by Indication
11.3.4.4.3 Rest of South & Central America: South & Central America Vaccines Market Share - by Route Of Administration
11.3.4.4.4 Rest of South & Central America: South & Central America Vaccines Market Share - by Age Group
12 COMPETITIVE LANDSCAPE
12.1 Heat Map Analysis by Key Players
12.2 Company Positioning & Concentration
13 INDUSTRY LANDSCAPE
13.1 Overview
13.2 New Product Development
13.3 Merger and Acquisition
13.4 Other Strategic Developments
14 COMPANY PROFILES
14.1 Abbott Laboratories
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 GSK Plc
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Pfizer Inc
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Merck & Co Inc
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Novartis AG
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Sanofi SA
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 CSL Ltd
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Serum Institute of India Pvt Ltd
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 BioNTech SE
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Sinovac Biotech Ltd
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. APPENDIX
15.1 About The Insight Partners
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
2.2 Market Attractiveness
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. SOUTH & CENTRAL AMERICA VACCINES MARKET LANDSCAPE
4.1 Market Overview
4.2 PEST Analysis
5. VACCINES MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. VACCINES MARKET - SOUTH & CENTRAL AMERICA MARKET ANALYSIS
6.1 South & Central America Vaccines Market Revenue (US$ Million), 2024 - 2031
6.2 South & Central America Vaccines Market Forecast and Analysis
7. SOUTH & CENTRAL AMERICA VACCINES MARKET REVENUE ANALYSIS - BY TYPE
7.1 Conjugated
7.1.1 Overview
7.1.2 Conjugated: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Inactivated
7.2.1 Overview
7.2.2 Inactivated: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.3 Live
7.3.1 Overview
7.3.2 Live: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.4 Recombinant
7.4.1 Overview
7.4.2 Recombinant: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.5 Toxoid
7.5.1 Overview
7.5.2 Toxoid: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. SOUTH & CENTRAL AMERICA VACCINES MARKET REVENUE ANALYSIS - BY INDICATION
8.1 HPV
8.1.1 Overview
8.1.2 HPV: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 PCV
8.2.1 Overview
8.2.2 PCV: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3 DTP
8.3.1 Overview
8.3.2 DTP: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.4 Hepatitis
8.4.1 Overview
8.4.2 Hepatitis: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.5 Influenza
8.5.1 Overview
8.5.2 Influenza: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.6 Dengue
8.6.1 Overview
8.6.2 Dengue: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.7 Other
8.7.1 Overview
8.7.2 Other: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. SOUTH & CENTRAL AMERICA VACCINES MARKET REVENUE ANALYSIS - BY ROUTE OF ADMINISTRATION
9.1 Injection
9.1.1 Overview
9.1.2 Injection: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Oral
9.2.1 Overview
9.2.2 Oral: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.3 Other
9.3.1 Overview
9.3.2 Other: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. SOUTH & CENTRAL AMERICA VACCINES MARKET REVENUE ANALYSIS - BY AGE GROUP
10.1 Pediatric
10.1.1 Overview
10.1.2 Pediatric: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2 Adult
10.2.1 Overview
10.2.2 Adult: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11. SOUTH & CENTRAL AMERICA VACCINES MARKET - COUNTRY ANALYSIS
11.1 South & Central America
11.1.1 South & Central America Vaccines Market Revenue and Forecast and Analysis - by Country
11.1.1.1 South & Central America Vaccines Market Revenue and Forecast and Analysis - by Country
11.1.2.2 Brazil: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.1.2.2.1 Brazil: South & Central America Vaccines Market Share - by Type
11.1.2.2.2 Brazil: South & Central America Vaccines Market Share - by Indication
11.1.2.2.3 Brazil: South & Central America Vaccines Market Share - by Route Of Administration
11.1.2.2.4 Brazil: South & Central America Vaccines Market Share - by Age Group
11.2.3.3 Argentina: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.2.3.3.1 Argentina: South & Central America Vaccines Market Share - by Type
11.2.3.3.2 Argentina: South & Central America Vaccines Market Share - by Indication
11.2.3.3.3 Argentina: South & Central America Vaccines Market Share - by Route Of Administration
11.2.3.3.4 Argentina: South & Central America Vaccines Market Share - by Age Group
11.3.4.4 Rest of South & Central America: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.3.4.4.1 Rest of South & Central America: South & Central America Vaccines Market Share - by Type
11.3.4.4.2 Rest of South & Central America: South & Central America Vaccines Market Share - by Indication
11.3.4.4.3 Rest of South & Central America: South & Central America Vaccines Market Share - by Route Of Administration
11.3.4.4.4 Rest of South & Central America: South & Central America Vaccines Market Share - by Age Group
12 COMPETITIVE LANDSCAPE
12.1 Heat Map Analysis by Key Players
12.2 Company Positioning & Concentration
13 INDUSTRY LANDSCAPE
13.1 Overview
13.2 New Product Development
13.3 Merger and Acquisition
13.4 Other Strategic Developments
14 COMPANY PROFILES
14.1 Abbott Laboratories
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 GSK Plc
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Pfizer Inc
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Merck & Co Inc
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Novartis AG
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Sanofi SA
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 CSL Ltd
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Serum Institute of India Pvt Ltd
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 BioNTech SE
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Sinovac Biotech Ltd
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. APPENDIX
15.1 About The Insight Partners
LIST OF TABLES
Table 1. South & Central America Vaccines Market Segmentation
Table 2. List of Vendors
Table 3. South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 5. South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 6. South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 7. South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 8. South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 9. Brazil: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 10. Brazil: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 11. Brazil: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 12. Brazil: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 13. Argentina: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 14. Argentina: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 15. Argentina: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 16. Argentina: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 17. Rest of South & Central America: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 18. Rest of South & Central America: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 19. Rest of South & Central America: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 20. Rest of South & Central America: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 21. Heat Map Analysis by Key Players
Table 1. South & Central America Vaccines Market Segmentation
Table 2. List of Vendors
Table 3. South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 5. South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 6. South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 7. South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 8. South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 9. Brazil: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 10. Brazil: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 11. Brazil: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 12. Brazil: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 13. Argentina: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 14. Argentina: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 15. Argentina: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 16. Argentina: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 17. Rest of South & Central America: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 18. Rest of South & Central America: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 19. Rest of South & Central America: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 20. Rest of South & Central America: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 21. Heat Map Analysis by Key Players
LIST OF FIGURES
Figure 1. South & Central America Vaccines Market Segmentation - Country
Figure 2. PEST Analysis
Figure 3. Ecosystem: Vaccines Market
Figure 4. South & Central America Vaccines Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. South & Central America Vaccines Market Revenue (US$ Million), 2024 - 2031
Figure 7. South & Central America Vaccines Market Share (%) - by Type, 2024 and 2031
Figure 8. Conjugated: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Inactivated: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Live: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 11. Recombinant: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Toxoid: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. South & Central America Vaccines Market Share (%) - by Indication, 2024 and 2031
Figure 14. HPV: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. PCV: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. DTP: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 17. Hepatitis: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Influenza: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. Dengue: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 20. Other: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. South & Central America Vaccines Market Share (%) - by Route Of Administration, 2024 and 2031
Figure 22. Injection: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. Oral: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 24. Other: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. South & Central America Vaccines Market Share (%) - by Age Group, 2024 and 2031
Figure 26. Pediatric: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 27. Adult: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 28. South & Central America Vaccines Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 29. Brazil: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 30. Argentina: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 31. Rest of South & Central America: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 32. Company Positioning & Concentration
Figure 1. South & Central America Vaccines Market Segmentation - Country
Figure 2. PEST Analysis
Figure 3. Ecosystem: Vaccines Market
Figure 4. South & Central America Vaccines Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. South & Central America Vaccines Market Revenue (US$ Million), 2024 - 2031
Figure 7. South & Central America Vaccines Market Share (%) - by Type, 2024 and 2031
Figure 8. Conjugated: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Inactivated: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Live: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 11. Recombinant: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Toxoid: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. South & Central America Vaccines Market Share (%) - by Indication, 2024 and 2031
Figure 14. HPV: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. PCV: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. DTP: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 17. Hepatitis: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Influenza: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. Dengue: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 20. Other: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. South & Central America Vaccines Market Share (%) - by Route Of Administration, 2024 and 2031
Figure 22. Injection: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. Oral: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 24. Other: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. South & Central America Vaccines Market Share (%) - by Age Group, 2024 and 2031
Figure 26. Pediatric: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 27. Adult: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 28. South & Central America Vaccines Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 29. Brazil: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 30. Argentina: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 31. Rest of South & Central America: South & Central America Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 32. Company Positioning & Concentration
